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The monoterpene indole alkaloids represent the largest family of alkaloid natural products
whose more than 2,000 members display a broad range of chemical diversity and potent
biological activity.1 The structural challenges presented by this family have long been a
source of interest, resulting in the development of a variety of inventive synthetic strategies
to access various family members. The biogenetically related natural alkaloids N-
methylaspidospermidine (1), N-methylquebrachamine (2), and tabernaebovine (3) represent
the aspidosperma subfamily of monoterpene indole alkaloids (Figure 1).2-5 The dimeric
alkaloid 3, isolated from Tabernaemontana bovina in 1998,2e has a fascinating molecular
constitution that exhibits a unique C2–C15′ linkage between two pentacyclic aspidosperma
skeletons. While elegant strategies for synthesis of other dimeric monoterpene indole
alkaloids have been reported,5 no synthetic solution to the distinctive C2–C15′ union
present in 3 exists. As an outgrowth of our laboratory's studies concerning electrophilic
amide activation,6 we report a concise and convergent strategy for the enantioselective
synthesis of alkaloids (–)-1, (+)-2, and dimeric (+)-dideepoxytabernaebovine (4).
Inspired by precedence in biogenetically relevant dimerizations of other monoterpene indole
alkaloids,1,5 we posited the biogenesis of (+)-tabernaebovine (3) to involve late-stage union
of two aspidosperma fragments at the C2–C15′ linkage. This retrobiosynthetic analysis7
prompted the development of a regio- and diastereoselective C2-arylation of pentacycle 5
(Scheme 1) en route to decacycle (+)-4. We envisioned that a highly electrophilic diiminium
ion 5 would allow for stereo- and regioselective transformations that provide divergent
access to dimeric decacycle (+)-4 as well as monomeric aspidosperma alkaloids such as
(–)-1 and (+)-2 (Scheme 1). We expected reduction of the diiminium ion 5 would afford
(–)-1, whereas hydrative Grob fragmentation followed by reduction would afford (+)-2. We
hypothesized that the diiminium ion 5 could be generated from lactam (–)-7 via a novel,
stereoselective double cyclization cascade. We envisioned a transformation involving
spirocyclization of an electrophilically activated lactam intermediate onto the 2-chloroindole
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and subsequent interruption of the Bischler–Napieralski reaction by cyclization of an
unactivated C3–C4 vinyl group onto the C2 position of the putative 2-
chlorospiroindoleninium intermediate 6. The overall stereochemical outcome of the process
would be secured from the resident stereochemistry of the C5 quaternary center. The
requisite lactam (–)-7 could be simplified via N-acylation and N-alkylation transforms to 2-
chlorotryptamine sulfonamide 8 and α-quaternary amide (+)-9, the latter of which could be
synthesized diastereoselectively via alkylative quaternization of an amide enolate.
The concise enantioselective synthesis of the key tryptamine-lactam (–)-7 is illustrated in
Scheme 2. Regioselective methylation of sulfonamide 108 via its disodium dianion provided
the requisite N1-methylated derivative in 91% yield. Subsequent treatment with N-
chlorosuccinimide afforded C2-chlorotryptamine 8 in 76% yield. The C5-quaternary
stereogenic center that we envisioned would enable stereocontrolled introduction of all
stereocenters found in alkaloids (–)-1, (+)-2, and (+)-4 was secured by successive
diastereoselective a-alkylations of crotonamide (+)-12. Acylation of (–)-pseudoephenamine
(11)10 with E-crotonyl chloride gave the enamide (+)-12 in 97% yield. Chemoselective γ–
deprotonation of enamide (+)-12 with lithium 2,2,6,6-tetramethylpiperidide in the presence
of lithium chloride, followed by electrophilic trapping of the resulting enolate with 3-
chloro-1-iodopropane afforded α-vinyl amide (+)-13 as a single diastereomer in 83% yield.
Inspired by Myers' alkylative quaternizations of pseudoephedrine amides and precedent for
(α)-alkylation of (α)-methyl crotonimides, we reasoned that deprotonation of (α)-vinyl
amide (+)-13 would afford the corresponding enolate with the sterically less demanding
vinyl group cis to the amide nitrogen. Alkylation from the less sterically shielded face of the
enolate10,11 would secure the desired C5 quaternary stereocenter. Gratifyingly,
deprotonation of amide (+)-13 with lithium diisopropylamide in the presence of lithium
chloride, followed by electrophilic trapping with iodoethane at −50 °C in the presence of
N,N′-dimethylpropylene urea provided the α-quaternary amide (+)-9 in 72% yield with an
excellent level of stereo selection (>29:1 dr).9,14,15
Attempts to hydrolyze amide (+)-9 to the corresponding carboxylic acid were unsatisfactory
due to competitive lactone formation under either basic or acidic conditions. Initial efforts to
couple (α)-quaternary amide (+)-9 with sulfonamide 8 via nucleophilic displacement of the
C8-chloride proved inefficient; fast N→O acyl transfer of amide (+)-9 led to intramolecular
N-alkylation. This propensity of amide (+)-9, however, could be used to our advantage for
the synthesis of lactam (–)-7 and recovery of the chiral auxiliary. Sequential treatment of
sulfonamide 8 with potassium hydride and O-silyl derivative (+)-14 in DMF followed by
heating to 100 °C afforded N-alkylated sulfonamide (+)-15 in 86% yield. Desulfonylation16
of (+)-15 to the corresponding secondary amine and in situ desilylation and heating in
ethanol afforded the key lactam (–)-7 in 95% yield and 94% ee.9 This single-step
transformation, which occurs via a desilylation/N→O acyl transfer/lactam cyclization
cascade, also leads to efficient recovery of the chiral auxiliary (–)-11 in 99% yield (Scheme
2).17
We next focused on the development of a unified strategy to access a versatile intermediate
en route to alkaloids (–)-1, (+)-2, and (+)-4. Electrophilic activation of lactam (–)-7 with
trifluoro-methanesulfonic anhydride6,18 initiated a double cyclization cascade leading to the
versatile diiminium ion 5 (Scheme 3). Guided by our prior studies of azaheterocycle
synthesis employing electrophilic amide activation,6 we recognized the optimal conditions
for conversion of lactam (–)-7 to diiminium ion 5 involve the use of mildly basic additive 3-
cyanopyridine in acetonitrile followed by warming. This transformation relies on C19-
electrophilic activation of lactam (–)-7 and rapid C12-nucleophilic spirocyclization
affording the putative 2-chlorospiroindoleninium intermediate 6 (Scheme 1) that undergoes
C2-addition by the vinyl group and loss of hydrogen chloride. The ability to employ an
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unactivated C3–C4 olefin as the nucleophile in the second cyclization is likely due to the
enhanced C2-electrophilicity of intermediate 6 imparted by the chlorine atom,19 together
with a high resilience of 6 toward an undesired Pictet–Spengler rearrangement.20,21
Consistent with the sensitivity of this double cyclization step, the use of less basic 2-
chloropyridine or more nucleophilic pyridine as the additive gave the desired diiminium ion
5 with reduced efficiency as evidenced by the presence of singly cyclized side-products,
recovered starting material, and significant decomposition.22 The synthetic versatility of
diiminium ion 5 is illustrated by its conversion to alkaloids (–)-1, (+)-2, and (–)-17 (Scheme
3). In situ reduction of intermediate 5 with sodium cyanoborohydride furnished (–)-
Nmethyldehydroaspidospermidine (16) in 50% yield as a single diastereomer. Catalytic
hydrogenation of cis-alkene (–)-16 with a carbon-supported platinum catalyst afforded (–)-
N-methylaspidospermidine (1) {[α]24D = −23 (c 0.17, CHCl3); lit. [α]25D= −23 (c 1.1,
CHCl3);3d for (+)-1, [α]20D= +24 (c 1.25, CHCl3)2c} in quantitative yield (Scheme 3). All
spectroscopic data for our synthetic (–)-1 was consistent with those reported in the
literature.3d The concise enantioselective synthesis of lactam (–)-7 combined with the
double cyclization strategy described above enables rapid access to useful intermediates
with highly reactive C2-and C19-iminium functions.
The unique reactivity of diiminium ion 5 is demonstrated by its utility in a C2-arylation
reminiscent of the C2–C15′ bond adjoining the two halves of the complex natural alkaloid
(+)-tabernaebovine (3, Figure 1). We reasoned that the vicinal C19 iminium ion of
intermediate5would enhance the electrophilicity of the C2 iminium ion both inductively and
by reducing the steric environment through the flattening of the DE–ring system.
Gratifyingly, treatment of in situ generated diiminium ion 5 with 4-(N,N-dimethylamino)
phenyl magnesium bromide at −40 °C for 30 seconds followed by addition of Red-Al
afforded hexacyclic C2-aniline adduct (–)-17 in 40% yield as a single diastereomer (Scheme
3).9 The steric congestion about C2 in adduct (–)-17 is evidenced by the ∼20 kcal/mol
barrier to rotation9 about the C2–C23 σ-bond as measured through NMR coalescence
temperature experiments. Additionally, heating an acidic aqueous solution of diiminium ion
5 to 70 °C effected Grob fragmentation to give the tetracyclic lactam (–)-1823 in 57% yield
in a single step from lactam (–)-7. Platinum catalyzed hydrogenation24 of the C3–C4 olefin
and subsequent C19-carbonyl reduction with lithium aluminium hydride at 60 °C provided
(+)-N-methylquebrachamine (2) {[α]24D= +102 (c 0.22, CHCl3); lit. [α]24D= +110
(CHCl3)2a} in 82% yield over two steps.9
With particular interest in evaluating this chemistry as a general entry to the synthesis of
complex aspidosperma alkaloids, we investigated a series of C2-addition reactions of
relevance in synthetic planning. Importantly, lactam (–)-18, requiring mild activation
conditions, proved to be an excellent precursor to diiminium ion 5. Treatment of lactam
(–)-18 with Tf2O–2-chloropyridine reagent combination6 in acetonitrile (23 °C, 10 min)
resulted in rapid stereo- and regioselective electrophilic transannular spirocyclization to 5 en
route to various C2-adducts 16–23 (Table 1). Introduction of sodium cyanoborohydride
afforded (–)-N-methyldehydroaspidospermidine (16) in 95% yield (Table 1, entry 1)
consistent with efficient generation of the same electrophilic intermediate 5 accessed from
lactam (–)-7 (Scheme 3). The greater reactivity at C2 compared to C19 of diiminium ion
5can be used for regioselective addition of the first nucleophile at the former. For example,
treatment of 5 with tributylstannane, followed by introduction of sodium borodeuteride,
afforded C19-deuterated pentacycle (–)-19 in 94% yield with no deuterium enrichment at C2
and 93% deuterium incorporation at C19 (Table 1, entry 2). Notably, the C2-arylated
product (–)-17 could be prepared efficiently from lactam (–)-18 using 4-(N,N-
dimethylamino) phenyl magnesium bromide as the first nucleophile followed by in situ C19
reduction (Table 1, entry 3, 76% yield). Alternatively, hexacyclic iminium triflate (–)-20
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could be isolated then reduced with sodium cyanoborohydride to (–)-17 in a subsequent step
(Table 1, entries 4 and 9). That this C19 reduction of pentacycle (–)-20 occurs in the absence
of an acidic additive is consistent with its spectroscopic data revealing its iminium ion
structure.9 It is notable that the ∼12 kcal/mol barrier to rotation9 about the C2–C23 σ-bond
in iminium ion (–)-20 is significantly lower than in the reduced product (–)-17 (vide supra),
consistent with the aforementioned structural flattening effect of the C19 iminium ion. The
high electrophilicity of diiminium ion 5 allows for C–C bond formation at C2 with highly
hindered and mildly nucleophilic species. Treatment of intermediate 5 with 2,6-
dimethylphenyl magnesium bromide followed by hydride reduction afforded the highly
congested xylene adduct (–)-21 in 59% yield (Table 1, entry 5). The high degree of steric
congestion about C2 in (–)-21 is evidenced by the complete lack of observable C2–C23 σ -
bond rotation on the 1H NMR timescale, even at 140 °C. Reaction of 5 with 2-
methallyltrimethylsilane or 1-(tert-butyldimethylsilyloxy)-1-methoxyethene and subsequent
hydride reduction afforded methallyl adduct (–)-22 (Table 1, entry 6, 92% yield) or methyl
acetate adduct (–)-23 (Table 1, entry 7, 79% yield), respectively. The utility of this strategy
to access C2-arylated derivatives is highlighted by a Friedel–Crafts reaction of 5 with N,N-
dimethylaniline (23 °C, 90 min) and either in situ C19 reduction to provide C2-arylated
amine (–)-17 or isolation of the pentacyclic C19-iminium salt (–)-20 (Table 1, entries 8 and
9, 74% and 73% yield, respectively).
With insight gained from these studies, in particular entries 8 and 9 of Table 1, we sought to
implement this chemistry in effecting the dimerization of two pentacyclic aspidosperma type
molecular frameworks at the challenging C2–C15′ linkage (Scheme 5). In the event,
electrophilic activation of tetracyclic lactam (–)-18 followed by treatment with equimolar
(–)-N-methyldehydroaspidospermidine (16) and heating to 85 °C afforded the decacyclic
iminium triflate (+)-24 in 80% yield. Subsequent C19-reduction of (+)-24 gave (–)-
didehydrodideepoxytabernaebovine (25), which upon hydrogenation provided (+)-
dideepoxytabernaebovine(4) in 64% yield over two steps (Scheme 5). Alternatively, in situ
C19 reduction of dimeric iminium ion (+)-24, formed through the union of lactam (–)-18
with (–)-N-methyldehydroaspidospermidine(16) as described above, with sodium
cyanoborohydride directly afforded product (–)-25 from (–)-18 in 73% yield.9 Apart from
increasing the electrophilicity of the vicinal C2 iminium ion, the C19 iminium ion may be
responsible for reducing the nucleophilicity of the dimeric intermediate (+)-24, as no
oligomerized products could be observed even when only one equivalent of (–)-16 was
employed as nucleophile.
We have developed a concise synthetic strategy to access the aspidosperma type molecular
framework employing a double cyclization cascade that sets up to three contiguous
stereogenic centers and forms up to three carbon-carbon bonds with complete regio- and
stereochemical control in a single step. The use of the chiral auxiliary (–)-1110 was critical
in enabling our concise and enantioselective synthesis of the key intermediate (–)-7. The
ability to use an unactivated olefin as a pendant nucleophile minimizes the need for
functional group removal and allows for concise and convergent access to complex
aspidosperma alkaloids. We have shown putative diiminium ion 5 to be a highly reactive
and versatile intermediate, allowing the rapid enantioselective total syntheses of (–)-N-
methylaspidospermidine (1) and (+)-N-methylquebrachamine (2) in 8 and 9 steps,
respectively, from E-crotonyl chloride and (–)-pseudoephenamine (11), as well as the
unprecedented C-C bond formations onto the highly congested C2 position of the
aspidosperma skeleton. The power of this synthetic strategy has been demonstrated in the
first example of a C2-C15′ dimerization of two aspidosperma type systems, a complex
assembly drawing on biogenetic considerations of (+)-3, in the synthesis of (+)-
dideepoxytabernaebovine (4).
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Figure 1.
Representative aspidosperma alkaloids.
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Scheme 1.
Retrosynthetic analysis of the aspidosperma alkaloids.
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Scheme 2.
Enantioselective synthesis of lactam (–)-7: a) NaH, DMF, 23 °C; MeI, 0→23 °C, 91%. b)
N-chlorosuccinimide, MeCN, 23 °C, 76%. c) E-crotonyl chloride, Et3N, THF, −30→23 °C,
97%. d) lithium 2,2,6,6-tetramethylpiperidide, LiCl, THF, 0→−78 °C; 3-chloro-1-
iodopropane, −78→0 °C, 83%. e) lithium diisopropylamide, LiCl, THF, −78→0 °C; N,N′-
dimethylpropylene urea, −40 °C; EtI, −50 °C, 72%, >29:1 dr. f) triethylsilyl triflate, 2,6-
lutidine, CH2Cl2, 23 °C, 100%. g) (+)-14, 8, KH, n-Bu4NI, DMF, 100 °C, 86%. h) PhSH,
K2CO3, DMSO, 23 °C; KOEt, Et3N•3HF, EtOH, 85 °C, 95%, 94% ee, 99% recovery of
(–)-11. DMF = N,N′-dimethylformamide, Ns = 2-nitrobenzenesulfonyl, TES = triethylsilyl.
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Scheme 3.
Synthesis of aspidosperma alkaloids by interception of diiminium ion 5: a) Tf2O, 3-
cyanopyridine, MeCN, 85 °C. i) NaBH3CN, THF, 50%. ii) 4-(Me2N)-C6H4MgBr, −40 °C;
Red-Al, 40%. iii) trifluoroacetic acid, sodium trifluoroacetate, H2O, 70 °C, 57%. b) H2, Pt/
C, THF, 100%. c) H2, Pt/C, THF. d) LiAlH4, THF, 65 °C, 82% (two steps). Tf2O =
trifluoromethanesulfonic anhydride.
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Scheme 5.
Synthesis of (+)-dideepoxytabernaebovine(4): a) Tf2O, 2-ClPyr, MeCN, 23 °C; (–)-16 (1.0
equiv), 85 °C, 80%. b) Red-Al, 0 °C, 76%. c) H2, Pt/C, THF, 84%.
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Table 1
Regio- and stereoselective transformations of lactam (–)-18.
aGrignard reagents at −40 °C. Other nucleophiles at 23 °C.
b
Isolated yield of single diastereomer.
c93% Deuterium incorporation at C19.
d
Isolated as C19 iminium triflate. 2-ClPyr = 2-chloropyridine.
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